baber/WOPTO huggingface dataset:
Patent NZ-540653-A (NZ)
Title: A process for the preparation of racemic citalopram diol and/or S- or R- citalopram diols and the use of such diols for the preparation of racemic citalopram, R-citalopram and/or S-citalopram
Inventor: PETERSEN HANS
IPC: C07C253/34
Filed: 2003-12-18
Abstract: Disclosed is a process for the preparation of racemic citalopram diol free base and/or acid addition salt and/or R- or S-citalopram diol free base and/or acid addition salt comprising a separation of an initial non-racemic mixture of R- and S-citalopram diol free base and/or acid addition salt with more than 50% of one of the enantiomers into a fraction being enriched with S-citalopram diol or R-citalopram diol free base and/or acid addition salt and a fraction comprising RS- citalopram diol free base and/or acid addition salt wherein the ratio of R-citalopram diol:S-citalopram diol is equal to 1:1 or closer to 1:1 than in the initial mixture of R- and S-citalopram diol characterized in that: i) RS-citalopram diol free base and/or acid addition salt is precipitated from a solution of the initial non-racemic mixture of R- and S-citalopram diol free base and/or acid addition salt; or R- or S-citalopram diol free base and/or acid addition salt is dissolved into a solvent from the initial non-racemic mixture of R- and S-citalopram diol free base and/or acid addition salt in said solvent, leaving a residue comprising RS-citalopram diol free base and/or acid addition salt; ii) the residue/precipitate formed is separated from the final solution phase; iia) if the residue/precipitate is crystalline it is optionally recrystallised one or more times to form racemic diol; iib) if the residue/precipitate is not crystalline, steps i) and ii) are optionally repeated until a crystalline residue/precipitate is obtained and the crystalline residue/precipitate is optionally recrystallised one or more times to form racemic diol; iii) the final solution phase is optionally subjected to further purification and S-citalopram diol or R-citalopram diol free base and/or acid addition salt is isolated from the final solution phase; iv) the free bases of the diols obtained are optionally converted to acid addition salts thereof or acid addition salts of the diols obtained are optionally converted to other acid addition salts or acid addition salts of the diols obtained are optionally converted to the corresponding free bases.
Patent NZ-541157-A (NZ)
Title: Polyester fiber structures
Inventor: INAGAKI KENJI
IPC: D04H1/42
Filed: 2003-12-25
Abstract: Disclosed are polyester fiber structures having good colour tones (low b* values) and being excellent in moldability made from polyester fiber produced in the presence of a catalyst which comprises (1) a mixture consisting of a Titanium compound component and products of reaction of these alkoxides with carboxylic acids or anhydrides thereof and a Phosphorus compound component and/or (2) a product obtained by reacting a Titanium compound component composed of one or more members selected from among titanium alkoxides and products of reaction of these alkoxides with carboxylic acids or anhydrides thereof with a Phosphorus compound component.
Patent NZ-541696-A (NZ)
Title: Zip end stop and zip incorporating such
Inventor: STEWART MATTHEW JAMES
Filed: 2004-08-09
Abstract: A zip end stop for a jacket type zip has a pin box 161 attached to the bottom end of a female zip track 104 and has a rebate 165 or recess for the purposes of receiving a resilient latch attached to the bottom end of a tape or flange attached to the male zip track 103. When engaged the latch will be securely held in the rebate and resists longitudinal movement of the male profile relative to the female profile.
Patent NZ-547817-A (NZ)
Title: A cutting device, in particular for handheld cutting of bonding material
Inventor: DAVIES CHRISTOPHER
Filed: 2003-07-25
Abstract: A cutting device has a rearward handle 3 spaced from a forward blade carrier 2, the rearward handle 3 and forward blade carrier 2 being movable relative to one another permitting re-configuration of the device. The device includes a lubrication arrangement for delivering lubricant to the blade 76, which may include a lubricant reservoir 20 inside the rearward handle 3 and a delivery tube 24 to transport the lubricant to the blade 76 along a path internal to the blade carrier 2. An injector 25 or nozzle may be provided to dispense the lubricant to the region of the blade 76, and an actuator 23 to pump the lubricant fluid may be mounted on the exterior of the device.
Patent NZ-549197-A (NZ)
Title: Window blind system releasably attached to the window frame
Inventor: ALLSOPP REGINALD CHARLES
IPC: E06B9/266
Filed: 2006-02-03
Abstract: A frame system (30) for a window blind (35) is disclosed. The frame (30) includes at least two angle joints (50) connecting at least three extruded portions (40) to form a substantially rigid structure. The window blind (35) is attached to the frame. The frame system (30) is secured to a window with frame-securing clips (25) which are inserted between a window casing (20) and a glass pane (15) within the window casing. A support extending from each flange (25) has at least one engaging member, the engaging member being configured to releasably engage the frame.
Patent NZ-549325-A (NZ)
Title: Membrane body and relative production method
Inventor: MOLTA PIERCARLO
IPC: B32B37/22
Filed: 2005-01-18
Abstract: Membrane body (1) comprising at least one pair of panels (10, 11) connected together in an adhesive manner by respective facing faces (12, 13) and a plurality of tie rods (16) arranged stably between the panels according to a set pattern. Each tie rod has respective end portions. The body further comprises insulation means (15) arranged between the panels and associated with each tie rod to leave the tie rod longitudinally free between the panels. The tie rods are suitable for resisting a dual tensile membrane stress acting on each of the pair of panels, and keeping the panels substantially free of tension during use. The second panel (11) covers the face (12) of the first panel (10) in such a way that the second panel adheres integrally to the first panel.
Patent NZ-552259-A (NZ)
Title: Means and methods for controlling flowering in plants
Inventor: NIELSEN KLAUS K
IPC: C07K14/415
Filed: 2005-07-07
Abstract: Disclosed is a polynucleotide which, when expressed in sense orientation in plants leads to a prevention of flowering, selected from the group consisting of (a) polynucleotides comprising a nucleotide sequence encoding a polypeptide with the amino acid sequence of SEQ ID NO:2; (b) polynucleotides comprising the coding region of the nucleotide sequence shown in SEQ ID NO:1; (c) polynucleotides comprising a nucleotide sequence encoding a fragment of the polypeptide encoded by a polynucleotide of (a) or (b), wherein said nucleotide sequence when expressed in sense orientation in plants leads to a prevention of flowering; (d) polynucleotides comprising a nucleotide sequence having a sequence identity of at least 50% with a polynucleotide of anyone of (a) to (c) and which when expressed in sense orientation in plants leads to a prevention of flowering; (e) polynucleotides comprising a nucleotide sequence the complementary strand of which hybridizes to the polynucleotide of anyone of (a) to (c), wherein said nucleotide sequence when expressed in sense orientation in plants leads to a prevention of flowering; and (f) polynucleotides comprising a nucleotide sequence that deviates from the nucleotide sequence defined in (e) by the degeneracy of the genetic code.
Patent NZ-564763-A (NZ)
Title: Polymorphisms in fatty acid binding protein 4(fabp4) gene and their associations with measures of marbling and subcutaneous fat depth in beef cattle
Inventor: JIANG ZHIHUA
IPC: C12Q1/68
Filed: 2006-05-26
Abstract: Provided is a method for identifying a bovine animal having desirable marbling, sub-cutaneous fat depth, or a combination thereof, as compared to the general population of bovine animals, comprising: (a) obtaining a biological sample from said bovine animal, said biological sample comprising nucleic acids encoding the bovine fatty acid binding protein ("FABP4") gene from said bovine; (b) detecting in said nucleic acids the presence of: (i) a C in one or both alleles of the FABP4 gene at position corresponding to position 7516; or (ii) a C in one or both alleles of the FABP4 gene at position corresponding to position 7713; and (c) correlating the presence of the nucleic acid content of (b) with desirable marbling, sub-cutaneous fat depth, or a combination thereof in said bovine animal. Further provided are interactive computer systems for tracking the rearing of bovines.
Patent NZ-565006-A (NZ)
Title: An insulating glass unit where the spacers and connectors are fused together by the application of heat
Inventor: GALLAGHER RAYMOND G
IPC: E06B3/667
Filed: 2006-07-28
Abstract: A spacer frame arrangement for insulating glass units is disclosed. The frame consists of a spacer profile body (1) and a connector. The spacer profile body (1) extends in a first direction and has a predetermined cross section in a plane perpendicular to the first direction. The predetermined cross section is constant along the first direction and defines a hollow inner space (7) of the spacer profile body with predetermined dimensions in the plane perpendicular to the first direction. The spacer profile body (1) is formed by a thermoplastic material, at least on the inside limiting the inner space (7). The connector comprises a connector section adapted to be inserted in the first direction into the hollow inner space (7). The outer surface of the connector section facing the inner surface of the hollow inner space (7) is made of a thermoplastic material, compatible in forming fused interfaces with the inside material of the spacer profile body (1). Melting at the interface at a temperature less than 315 degC causes the inner surface of the spacer profile (1) and the connector to be at least partly connected by melt fusing.
Patent NZ-573744-A (NZ)
Title: A tensioner
Inventor: HOGG MALCOLM ERNEST
IPC: B21F9/00
Filed: 2008-12-19
Abstract: A cost effective and simple wire tensioner 1, comprises a body 4 around which the wire can be wound with a recess 8 in the body into which the wire may be inserted, and first and second locking portions 17, 18 where the first and second locking portions 17, 18 extend away from the body 4 and in opposite directions to each other.
Patent NZ-577614-A (NZ)
Title: Method of inserting non-speech data into trunk packets containing speech data
Inventor: HILL ADAM
IPC: H04L29/06
Filed: 2007-10-30
Abstract: Disclosed is a method of transmitting speech packets and non-speech packets between computing devices. The speech packets are transmitted through a routing device on a network link using networking protocols. The method is performed by constructing, at successive intervals, a trunk packet of a predetermined maximum size and transmitting the trunk packet. Constructing the trunk packet includes adding speech packets queued for transmission to the packet and, where there is space left in the trunk packet, adding non-speech packets queued for transmission to the trunk packet. These non-speech packets are added to the trunk packet until it reaches the predetermined maximum size.
Patent NZ-580488-A (NZ)
Title: Food spraying process wherein height of a nozzle achieves spray having vertical drizzle with cylindrical cross-section
Inventor: BESSE NICOLAS
IPC: A23G1/00
Filed: 2008-04-18
Abstract: A process for applying a layer of at least fat and sugar on a surface of an edible product (40) is disclosed. The product (40) is submitted to at least two spraying stages. Each spaying stage involves at least one nozzle (3) generating a conical jet (31) having an angle (á) and a vertical axis. The nozzle (3) is positioned between 200mm and 800 mm above the product (40). This height (H) allows for the jet (31) to comprise a vertically oriented drizzle (32) having a substantially cylindrical cross-section, as shown in the drawing.
Patent NZ-594545-A (NZ)
Title: Transmucosal delivery devices with enhanced uptake containing fentanyl or buprenorphine
Inventor: VASISHT NIRAJ
IPC: A61K9/00
Filed: 2007-07-23
Abstract: Disclosed is a mucoadhesive delivery device suitable for transrnucosal administration of an effective amount of a fentanyl compound to a subject, the mucoadhesive device comprising a fentanyl compound disposed in a mucoadhesive polymeric diffusion environment which has a pH between 6.5 and 8; and a barrier layer disposed relative to the mucoadhesive polymeric diffusion environment such that a unidirectional gradient is created upon application of the device to a mucosal surface.
Patent NZ-596501-A (NZ)
Title: Casb7439 constructs
Inventor: RIOUX CLEMENT
IPC: A61K38/00
Filed: 2010-05-25
Abstract: 596287 Discloses a protein construct comprising CASB7439 (HASH2) polypeptide, wherein the peptide is used in an immunogenic composition. Further discloses where the composition or peptide is used in the manufacture of a medicament, where the medicament is used in a method for providing an immune response to said protein.
Patent NZ-596616-A (NZ)
Title: Aminopyrazole triazolothiadiazole inhibitors of c-met protien kinase
Inventor: LAUFFER DAVID
IPC: A61K31/4196
Filed: 2010-05-27
Abstract: 596616 Disclosed is a compound having the formula (1), wherein R1, R2, R3, R4 and R5 are defined herein, and a pharmaceutical composition comprising said compound additionally comprising a chemotherapeutic or anti-proliferative agent, an anti-inflammatory agent, an agent for treating atherosclerosis, or an agent for treating lung fibrosis. Specific embodiments of the compound include: 3-(difluoro(quinolin-6-yl)methyl)-N-(1-methyl-1H-pyrazol-4-yl)-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazol-6-amine, and 3-(difluoro(quinolin-6-yl)methyl)-N-(1,3-dimethyl-1H-pyrazol-4-yl)-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazol-6-amine.
Patent NZ-598021-A (NZ)
Title: Prodrugs comprising an insulin linker conjugate
Inventor: RAU HARALD
IPC: A61K38/28
Filed: 2010-07-30
Abstract: Disclosed herein is a prodrug or a pharmaceutically acceptable salt thereof comprising an insulin linker conjugate D-L, wherein D represents the insulin moiety; and -L is a non-biologically active linker moiety -L1 represented by formula (I), wherein the dashed line indicates the attachment to one of the amino groups of the insulin by forming an amide bond. Additionally disclosed are pharmaceutical compositions comprising said prodrugs as well as their use as a medicament for treating or preventing diseases or disorders which can be treated by insulin.
Patent NZ-600375-A (NZ)
Title: Herbicide tolerant soybean plants and methods for identifying same
Inventor: MASON JUSTIN THOMAS
IPC: C12Q1/68
Filed: 2010-11-23
Abstract: Disclosed is a soybean plant, cell, tissue or seed, comprising EE-GM3 and EE-GM2, comprising in the genome of its cells the nucleic acid sequence of SEQ ID NO: 2 from nucleotide 1431 to 1472 or a sequence at least 95% identical thereto and the nucleic acid sequence of SEQ ID No: 3 from nucleotide 220 to 261 or a sequence at least 95% identical thereto, or the complement of said sequences, and also the nucleic acid sequence of SEQ ID No: 14 from nucleotide 301 to 322 and the nucleic acid sequence of SEQ ID NO: 15 from nucleotide 497 to 518, or the complement of said sequences, wherein the sequences are as defined in the complete specification. Also disclosed is a method for controlling weeds in a field of soybean plants comprising events EE-GM3 and EE-GM2, comprising treating the field with an effective amount of an isoxaflutolebased, glyphosate-based and/or glufosinate-based herbicide, wherein such plants are tolerant to such herbicide(s).
Patent NZ-602611-A (NZ)
Title: Replication-defective flavivirus vaccines and vaccine vectors
Inventor: PUGACHEV KONSTANTIN V
IPC: A61K39/12
Filed: 2009-03-16
Abstract: Disclosed is a replication-deficient pseudoinfectious flavivirus comprising a yellow fever or West Nile virus genome comprising (i) a deletion in nucleotide sequences encoding amino acids 20 to 100 of capsid (C), and a deletion within nucleotide sequences encoding a premembrane (prM) and/or envelope (E) protein, and (ii) a sequence encoding one or more heterologous pathogen immunogens inserted in the place of or in combination with the deletion of the pre-membrane (prM) and/or envelope (E) protein, wherein the pathogen is selected from the group consisting of a rabies virus, Borrelia burgdorferi, an influenza virus, a human immunodeficiency virus, a simian immunodeficiency virus, a human papilloma virus, a respiratory syncytial virus, a malaria parasite, and Mycobacterium tuberculosis.
Patent NZ-602984-A (NZ)
Title: A system for covering the side of a shelving bay
Inventor: PARKER BRIAN MAURICE
IPC: A47B53/00
Filed: 2011-08-04
Abstract: 602984 A system is disclosed for covering a side frame of a shelving unit that may have one or more shelving bays. The system includes at least two extrusions attachable to side corners of each bay. A cover panel projects outwardly from the side frame and is removably attachable to the first and second extrusions along the side edges so that the cover panel covers the side frame. The cover panel is stated to be aesthetically pleasing and can also cover various components such as drive assemblies.
Patent NZ-613950-A (NZ)
Title: Method for promoting plant growth
Inventor: MATSUSHIMA YUTAKA
IPC: A01P21/00
Filed: 2012-03-28
Abstract: Disclosed is a method for promoting the growth of a plant which comprises treating the plant with an effective amount of a compound represented by general formula (1), wherein the substituents are as described in the specification, which include compounds N-methyl-2-[2-(2,5-dimethylphenoxy)methyl]phenyl-2-methoxyacetamide and (2) N-methyl-2-[2-(2,5-dimethylphenoxy)methyl]phenyl(2R)-2-methoxyacetamide. Plant growth is promoted by spraying compounds of formula (1) onto soil or seeds where plants have been, or may be exposed to abiotic stress.
Patent NZ-617130-A (NZ)
Title: Treatment of neurodegeneration and neuroinflammation
Inventor: LUKASHEV MATVEY
IPC: A61K31/195
Filed: 2010-04-29
Abstract: An ex-vivo method of analyzing the effect of dimethyl fumarate (DMF) or monomethyl fumarate (MMF) in a subject having a condition characterized by at least one symptom chosen from neurodegeneration and neuroinflammation, the method comprising: measuring in a sample isolated from the subject, during treatment or after treatment with dimethyl fumarate or monomethyl fumarate, the expression level of at least one gene selected from the group consisting of Ccl20, Ccl3, Ccl4, Cxcl1, Cxcl10, Cxcl2, Cxcl3, Cxcl6, IL1a, Ifit3, Nfkbia, Nfkbiz, Tnfaip2, Zc3h12a, Ggt1, Srxn1, and Sqstm1; and comparing the expression level of the at least one gene in the sample isolated from the subject during or after treatment to the expression level of said at least one gene in a sample isolated from the subject at an earlier time.
Patent NZ-624700-A (NZ)
Title: Method of predicting breast cancer prognosis
Inventor: BAKER JOFFRE B
IPC: G01N33/50
Filed: 2012-11-02
Abstract: Discloses a method of predicting a likelihood of long-term survival without recurrence of breast cancer in a breast cancer patient, comprising: determining a level of the breast cancer prognostic biomarkers including: kinesin family member 1B (KIF1B); at least three RNA transcripts, or expression products thereof, are selected from ENO1, IDH2, TMSB10, PGK1, and G6PD; or at least five RNA transcripts, or expression products thereof, are selected from PGD, TKT, TALDO1, G6PD, GP1, SLC1A5, SLC7A5, OGDH, SUCLG1, ENO1, PGK1, IDH2, ACO2, and FBP1; in a breast cancer tumor sample obtained from the patient, normalizing the level of the breast cancer prognostic biomarkers to obtain a normalized level of biomarker and predicting a likelihood of long-term survival without recurrence of breast cancer of said patient, wherein an increased normalized level of the breast cancer prognostic biomarker is correlated with increased likelihood of long-term survival without recurrence of breast cancer.
Patent NZ-628398-A (NZ)
Title: Stable preservative-free mydriatic and anti-inflammatory solutions for injection
Inventor: DEMOPULOS GREGORY A
IPC: A61K47/12
Filed: 2013-10-23
Abstract: The present disclosure relates to stable, preservative- and antioxidant-free liquid formulations of phenylephrine and ketorolac for injection into intraocular ophthalmologic irrigation solutions. The formulations comprise phenylephrine, ketorolac, a buffer system such as a citric acid buffer and an aqueous carrier such as saline.
Patent NZ-701761-A (NZ)
Title: Self-test for analgesic product
Inventor: LEMKE JOHN
IPC: A61N1/30
Filed: 2013-03-05
Abstract: Electrotransport drug delivery devices, system and methods of using configured to determine if a current is present between the anode and cathode when drug is not intended to be delivered by the device. These devices/systems may include an off-current module to determine that any current (e.g., which may be inferred by measuring potential difference between the anode and cathode of the device) flowing between the anode and cathode is below a threshold value when the device is not supposed to be delivering drug, thereby preventing unintended delivery of drug and/or alerting a user that unintended delivery of drug may occur.
Patent NZ-706173-A (NZ)
Title: Nucleated polypropylene composition for containers
Inventor: JOHNSEN GEIR KRISTIAN
IPC: C08L23/14
Filed: 2013-08-02
Abstract: The present invention provides a moulded container for food packaging comprising, preferably consisting of, a polypropylene composition, the polypropylene composition comprising - a propylene homo- or copolymer (A) having (i) a melt flow rate, determined according to ISO 1133 at 230 °C and under a load of 2.16 kg, of at least 25 g/10 min; and (ii) in case component (A) is a copolymer, a comonomer content of not more than 5.0 wt.%; and a nucleating agent (B), as well as to the use of a polypropylene composition comprising - a propylene homo- or copolymer (A) having (i) a melt flow rate, determined according to ISO 1133 at 230°C and under a load of 2.16 kg, of at least 25 g/10 min; and (ii) in case component (A) is a copolymer, a comonomer content of not more than 5.0 wt.%; and a nucleating agent (B); for the manufacture of a moulded container.
Patent NZ-708297-A (NZ)
Title: Variable displacement container base
Inventor: WRIGHT PAUL LEE
IPC: B65D90/32
Filed: 2014-01-14
Abstract: The present invention is directed to an improved variable displacement container base which can accommodate different rates of cooling of liquids dispensed in a container. To achieve an improved variable displacement container base the present invention provides A base for a container, the base comprising: an outer support wall; a support surface extending inwardly from the outer support wall and defining a reference plane; an inner support wall extending upwardly from the support surface; a first radiused portion extending radially inward from the inner support wall and concave relative to the reference plane; a second radiused portion extending radially inward from the first radiused portion and convex relative to the reference plane; an intermediate surface extending radially inward from the second radiused portion and substantially parallel to the reference plane; a third radiused portion extending radially inward from the intermediate surface and convex relative to the reference plane; a central portion disposed proximate the third radiused portion, the central portion including an inner core having a sidewall and a top surface extending from the sidewall, the top surface having a convex portion relative the reference plane; and a transition portion between the third radiused portion and the inner core; as well as a container including such a base.